Atlas Trials

Intergruppo Melanoma Italiano

2 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Intergruppo Melanoma Italiano

RecordFirmDate
MELAFERT: Impact of Adjuvant Therapy on FERTility in Patients With Resected MELAnoma at High Risk of Relapse. (NCT07092670)Intergruppo Melanoma Italiano2025-08-04
To Evaluate the Efficacy Beyond Progression of Vemurafenib+Cobimetinib Associated With Local Treatment Compared to Second-line Treatment in Patients With BRAFV600+ Metastatic Melanoma in Focal Progression With First-line+Vemurafenib+Cobimetinib. (NCT03514901)Intergruppo Melanoma Italiano2018-06-18

Track Intergruppo Melanoma Italiano automatically

Every clearance here is in the API, with alerts when new ones post.